Our findings support previous reports describing elevated levels of [TIMP-2] × [IGFBP7] as predictors of adverse outcomes (e.g., death, dialysis, or progression to AKI in patients with septic shock) in various clinical conditions [32]; and imminent risk of AKI in critically ill patients [33]. Here, IGFBP7 is linked to acute kidney injury.